Table 1.
Informations and chemotherapy treatment of enrolled patients
| Samples | Sex | Age | Treatment |
|---|---|---|---|
| Healthy 1 | M | 50 | |
| Healthy 2 | F | 40 | |
| Healthy 3 | M | 28 | |
| Healthy 4 | F | 23 | |
| OT 1 | M | 72 | Cisplatin + vinorelbine |
| OT 2 | F | 73 | Gemcitabine |
| OT 3 | M | 72 | Carboplatin + gemcitabine |
| OT 4 | F | 68 | Cisplatin + etoposide |
| OT 5 | F | 81 | Carboplatin + alimta |
| OT 6 | M | 61 | Cisplatin + gemcitabine |
| OT 7 | M | 62 | Carboplatin + gemcitabine |
| OT 8 | F | 69 | Cisplatin + gemcitabine |
| OT 9 | M | 72 | Carboplatin + vinorelbine |
| OT 10 | M | 78 | Cisplatin + gemcitabine |
| OT 11 | F | 64 | Carboplatin + pemetrexed |
| OT 12 | F | 62 | Cisplatin + pemetrexed |
| OMA 1 | F | 61 | XELOX |
| OMA 2 | F | 54 | XELOX |
| OMA 3 | M | 56 | XELOX |
| OMA 4 | M | 62 | XELOX |
| OMA 5 | M | 52 | XELOX |
| OMA 6 | F | 60 | XELOX |
| OMA 7 | M | 62 | XELOX |
| OMA 8 | M | 60 | XELOX |
| OMA 9 | M | 66 | XELOX |
| OMA 10 | M | 55 | XELOX |
| OMA 11 | M | 66 | XELOX |